Copyright Reports & Markets. All rights reserved.

Global Surgical Hemostatic Forceps Market Research Report 2021

Request for Sample of this report
Buy now

1 Surgical Hemostatic Forceps Market Overview

  • 1.1 Product Overview and Scope of Surgical Hemostatic Forceps
  • 1.2 Surgical Hemostatic Forceps Segment by Type
    • 1.2.1 Global Surgical Hemostatic Forceps Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Straight Hemostatic Forceps
    • 1.2.3 Curved Hemostatic Forceps
    • 1.2.4 Others
  • 1.3 Surgical Hemostatic Forceps Segment by Application
    • 1.3.1 Surgical Hemostatic Forceps Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Emergency Center
    • 1.3.5 Others
  • 1.4 Global Surgical Hemostatic Forceps Market Size Estimates and Forecasts
    • 1.4.1 Global Surgical Hemostatic Forceps Revenue 2016-2027
    • 1.4.2 Global Surgical Hemostatic Forceps Sales 2016-2027
    • 1.4.3 Surgical Hemostatic Forceps Market Size by Region: 2016 Versus 2021 Versus 2027

2 Surgical Hemostatic Forceps Market Competition by Manufacturers

  • 2.1 Global Surgical Hemostatic Forceps Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Surgical Hemostatic Forceps Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Surgical Hemostatic Forceps Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Surgical Hemostatic Forceps Manufacturing Sites, Area Served, Product Type
  • 2.5 Surgical Hemostatic Forceps Market Competitive Situation and Trends
    • 2.5.1 Surgical Hemostatic Forceps Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Surgical Hemostatic Forceps Players Market Share by Revenue
    • 2.5.3 Global Surgical Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Surgical Hemostatic Forceps Retrospective Market Scenario by Region

  • 3.1 Global Surgical Hemostatic Forceps Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Surgical Hemostatic Forceps Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Surgical Hemostatic Forceps Market Facts & Figures by Country
    • 3.3.1 North America Surgical Hemostatic Forceps Sales by Country
    • 3.3.2 North America Surgical Hemostatic Forceps Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Surgical Hemostatic Forceps Market Facts & Figures by Country
    • 3.4.1 Europe Surgical Hemostatic Forceps Sales by Country
    • 3.4.2 Europe Surgical Hemostatic Forceps Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Surgical Hemostatic Forceps Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Surgical Hemostatic Forceps Sales by Region
    • 3.5.2 Asia Pacific Surgical Hemostatic Forceps Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Surgical Hemostatic Forceps Market Facts & Figures by Country
    • 3.6.1 Latin America Surgical Hemostatic Forceps Sales by Country
    • 3.6.2 Latin America Surgical Hemostatic Forceps Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Surgical Hemostatic Forceps Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Surgical Hemostatic Forceps Sales by Country
    • 3.7.2 Middle East and Africa Surgical Hemostatic Forceps Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Surgical Hemostatic Forceps Historic Market Analysis by Type

  • 4.1 Global Surgical Hemostatic Forceps Sales Market Share by Type (2016-2021)
  • 4.2 Global Surgical Hemostatic Forceps Revenue Market Share by Type (2016-2021)
  • 4.3 Global Surgical Hemostatic Forceps Price by Type (2016-2021)

5 Global Surgical Hemostatic Forceps Historic Market Analysis by Application

  • 5.1 Global Surgical Hemostatic Forceps Sales Market Share by Application (2016-2021)
  • 5.2 Global Surgical Hemostatic Forceps Revenue Market Share by Application (2016-2021)
  • 5.3 Global Surgical Hemostatic Forceps Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Medline
    • 6.1.1 Medline Corporation Information
    • 6.1.2 Medline Description and Business Overview
    • 6.1.3 Medline Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Medline Product Portfolio
    • 6.1.5 Medline Recent Developments/Updates
  • 6.2 B. Braun
    • 6.2.1 B. Braun Corporation Information
    • 6.2.2 B. Braun Description and Business Overview
    • 6.2.3 B. Braun Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 B. Braun Product Portfolio
    • 6.2.5 B. Braun Recent Developments/Updates
  • 6.3 CareFusion
    • 6.3.1 CareFusion Corporation Information
    • 6.3.2 CareFusion Description and Business Overview
    • 6.3.3 CareFusion Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 CareFusion Product Portfolio
    • 6.3.5 CareFusion Recent Developments/Updates
  • 6.4 Asa Dental
    • 6.4.1 Asa Dental Corporation Information
    • 6.4.2 Asa Dental Description and Business Overview
    • 6.4.3 Asa Dental Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Asa Dental Product Portfolio
    • 6.4.5 Asa Dental Recent Developments/Updates
  • 6.5 Sklar
    • 6.5.1 Sklar Corporation Information
    • 6.5.2 Sklar Description and Business Overview
    • 6.5.3 Sklar Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Sklar Product Portfolio
    • 6.5.5 Sklar Recent Developments/Updates
  • 6.6 Scanlan International
    • 6.6.1 Scanlan International Corporation Information
    • 6.6.2 Scanlan International Description and Business Overview
    • 6.6.3 Scanlan International Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Scanlan International Product Portfolio
    • 6.6.5 Scanlan International Recent Developments/Updates
  • 6.7 Shanghai Medical Instruments
    • 6.6.1 Shanghai Medical Instruments Corporation Information
    • 6.6.2 Shanghai Medical Instruments Description and Business Overview
    • 6.6.3 Shanghai Medical Instruments Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Shanghai Medical Instruments Product Portfolio
    • 6.7.5 Shanghai Medical Instruments Recent Developments/Updates
  • 6.8 Lawton
    • 6.8.1 Lawton Corporation Information
    • 6.8.2 Lawton Description and Business Overview
    • 6.8.3 Lawton Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Lawton Product Portfolio
    • 6.8.5 Lawton Recent Developments/Updates
  • 6.9 Hu-Friedy
    • 6.9.1 Hu-Friedy Corporation Information
    • 6.9.2 Hu-Friedy Description and Business Overview
    • 6.9.3 Hu-Friedy Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Hu-Friedy Product Portfolio
    • 6.9.5 Hu-Friedy Recent Developments/Updates
  • 6.10 Xinhua Surgical
    • 6.10.1 Xinhua Surgical Corporation Information
    • 6.10.2 Xinhua Surgical Description and Business Overview
    • 6.10.3 Xinhua Surgical Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Xinhua Surgical Product Portfolio
    • 6.10.5 Xinhua Surgical Recent Developments/Updates
  • 6.11 Towne Brothers
    • 6.11.1 Towne Brothers Corporation Information
    • 6.11.2 Towne Brothers Surgical Hemostatic Forceps Description and Business Overview
    • 6.11.3 Towne Brothers Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Towne Brothers Product Portfolio
    • 6.11.5 Towne Brothers Recent Developments/Updates
  • 6.12 Teleflex Medical
    • 6.12.1 Teleflex Medical Corporation Information
    • 6.12.2 Teleflex Medical Surgical Hemostatic Forceps Description and Business Overview
    • 6.12.3 Teleflex Medical Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Teleflex Medical Product Portfolio
    • 6.12.5 Teleflex Medical Recent Developments/Updates
  • 6.13 Delacroix Chevalier
    • 6.13.1 Delacroix Chevalier Corporation Information
    • 6.13.2 Delacroix Chevalier Surgical Hemostatic Forceps Description and Business Overview
    • 6.13.3 Delacroix Chevalier Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Delacroix Chevalier Product Portfolio
    • 6.13.5 Delacroix Chevalier Recent Developments/Updates
  • 6.14 YDM
    • 6.14.1 YDM Corporation Information
    • 6.14.2 YDM Surgical Hemostatic Forceps Description and Business Overview
    • 6.14.3 YDM Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 YDM Product Portfolio
    • 6.14.5 YDM Recent Developments/Updates
  • 6.15 M A Corporation
    • 6.15.1 M A Corporation Corporation Information
    • 6.15.2 M A Corporation Surgical Hemostatic Forceps Description and Business Overview
    • 6.15.3 M A Corporation Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 M A Corporation Product Portfolio
    • 6.15.5 M A Corporation Recent Developments/Updates
  • 6.16 MedGyn Products
    • 6.16.1 MedGyn Products Corporation Information
    • 6.16.2 MedGyn Products Surgical Hemostatic Forceps Description and Business Overview
    • 6.16.3 MedGyn Products Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 MedGyn Products Product Portfolio
    • 6.16.5 MedGyn Products Recent Developments/Updates
  • 6.17 Inami
    • 6.17.1 Inami Corporation Information
    • 6.17.2 Inami Surgical Hemostatic Forceps Description and Business Overview
    • 6.17.3 Inami Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Inami Product Portfolio
    • 6.17.5 Inami Recent Developments/Updates
  • 6.18 Ted Pella
    • 6.18.1 Ted Pella Corporation Information
    • 6.18.2 Ted Pella Surgical Hemostatic Forceps Description and Business Overview
    • 6.18.3 Ted Pella Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Ted Pella Product Portfolio
    • 6.18.5 Ted Pella Recent Developments/Updates
  • 6.19 Medicon eG
    • 6.19.1 Medicon eG Corporation Information
    • 6.19.2 Medicon eG Surgical Hemostatic Forceps Description and Business Overview
    • 6.19.3 Medicon eG Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Medicon eG Product Portfolio
    • 6.19.5 Medicon eG Recent Developments/Updates
  • 6.20 J & J Instruments
    • 6.20.1 J & J Instruments Corporation Information
    • 6.20.2 J & J Instruments Surgical Hemostatic Forceps Description and Business Overview
    • 6.20.3 J & J Instruments Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 J & J Instruments Product Portfolio
    • 6.20.5 J & J Instruments Recent Developments/Updates
  • 6.21 American Diagnostic
    • 6.21.1 American Diagnostic Corporation Information
    • 6.21.2 American Diagnostic Surgical Hemostatic Forceps Description and Business Overview
    • 6.21.3 American Diagnostic Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 American Diagnostic Product Portfolio
    • 6.21.5 American Diagnostic Recent Developments/Updates

7 Surgical Hemostatic Forceps Manufacturing Cost Analysis

  • 7.1 Surgical Hemostatic Forceps Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Surgical Hemostatic Forceps
  • 7.4 Surgical Hemostatic Forceps Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Surgical Hemostatic Forceps Distributors List
  • 8.3 Surgical Hemostatic Forceps Customers

9 Surgical Hemostatic Forceps Market Dynamics

  • 9.1 Surgical Hemostatic Forceps Industry Trends
  • 9.2 Surgical Hemostatic Forceps Growth Drivers
  • 9.3 Surgical Hemostatic Forceps Market Challenges
  • 9.4 Surgical Hemostatic Forceps Market Restraints

10 Global Market Forecast

  • 10.1 Surgical Hemostatic Forceps Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Surgical Hemostatic Forceps by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Surgical Hemostatic Forceps by Type (2022-2027)
  • 10.2 Surgical Hemostatic Forceps Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Surgical Hemostatic Forceps by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Surgical Hemostatic Forceps by Application (2022-2027)
  • 10.3 Surgical Hemostatic Forceps Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Surgical Hemostatic Forceps by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Surgical Hemostatic Forceps by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Straight Hemostatic Forceps
    Curved Hemostatic Forceps
    Others

    Segment by Application
    Hospital
    Clinic
    Emergency Center
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Medline
    B. Braun
    CareFusion
    Asa Dental
    Sklar
    Scanlan International
    Shanghai Medical Instruments
    Lawton
    Hu-Friedy
    Xinhua Surgical
    Towne Brothers
    Teleflex Medical
    Delacroix Chevalier
    YDM
    M A Corporation
    MedGyn Products
    Inami
    Ted Pella
    Medicon eG
    J & J Instruments
    American Diagnostic

    Buy now